Drug Profile


Alternative Names: RPT-835

Latest Information Update: 07 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Russian Pharmaceutical Technologies
  • Class Antineoplastics; Benzoic acids; Pyridines; Small molecules; Sulfonamides
  • Mechanism of Action Type-2 fibroblast growth factor receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Breast cancer; Ovarian cancer
  • No development reported Cancer

Most Recent Events

  • 03 Nov 2017 Chemical structure information added
  • 02 Nov 2017 Pharmacokinetics data from preclinical studies presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC 2017 (3281203)
  • 16 Jul 2016 No recent reports of development identified for research development in Cancer in Russia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top